Finance

Lists
688076:SHA
Jiangsu Sinopep Allsin Bphrmctcl Co Ltd
CNÂ¥28.92
+0.31%
(+0.090) 1D
Sep 28, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688076...
Open
CNÂ¥28.66
High
CNÂ¥29.11
Low
CNÂ¥28.55
Mkt. cap
9.13B
Avg. vol.
2.47M
Volume
1.95M
Dividend
1.21%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 12, 2026
P/E ratio
38.32
52-wk high
CNÂ¥41.90
52-wk low
CNÂ¥25.70
EPS
CNÂ¥0.75
No. of employees
2K
Open
CNÂ¥28.66
High
CNÂ¥29.11
Low
CNÂ¥28.55
Mkt. cap
9.13B
Avg. vol.
2.47M
Volume
1.95M
Dividend
1.21%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 12, 2026
P/E ratio
38.32
52-wk high
CNÂ¥41.90
52-wk low
CNÂ¥25.70
EPS
CNÂ¥0.75
No. of employees
2K
About Jiangsu Sinopep Allsin Bphrmctcl Co Ltd
CEO-
Employees2.36K
FoundedApr 3, 2009
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
478.90M
415.62M
552.98M
586.67M
Cost of goods sold
129.28M
327.84M
210.32M
251.28M
Cost of revenue
129.28M
327.84M
210.32M
251.28M
Research and development expenses
66.28M
65.36M
53.12M
25.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
86.65M
116.57M
87.52M
96.63M
Operating expense
154.38M
173.35M
151.33M
102.69M
Total operating expenses
283.66M
501.19M
361.65M
353.97M
Operating income
195.24M
-85.57M
191.33M
232.71M
Other non operating income
1.50M
633.51K
-8.53M
-141.09M
EBT including unusual items
151.68M
-130.96M
150.48M
88.42M
EBT excluding unusual items
177.52M
-105.91M
168.85M
107.03M
Income tax expense
7.74M
-10.06M
23.59M
5.67M
Effective tax rate
5.10%
7.68%
15.67%
6.41%
Other operating expenses
-2.65M
-4.39M
-5.99M
-3.15M
Net income
134.49M
-112.12M
129.46M
85.59M
Net profit margin
28.08%
-26.98%
23.41%
14.59%
Earnings per share
0.34
-0.21
0.39
-
Interest and investment income
3.20M
3.24M
2.24M
16.19M
Interest expense
-18.31M
-20.20M
-16.19M
-773.09K
Net interest expenses
-15.12M
-16.96M
-13.95M
15.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
245.71M
-10.31M
266.59M
328.40M
Gain or loss from assets sale
-
6.43K
-
-38.65K
AI content may include mistakes. Learn more
Google apps